We respond to the comment by Warburton and Roberts 1 in reply to our recent call for rationalization of resistance gene nomenclature. 2 The authors argue that there will be more genes if the ,80% amino acid identity of the protein currently used in the case of genes conferring resistance to tetracycline is raised to ,2% DNA or protein as we proposed. We agree that this will be the case and that making the change may involve significant effort for a few groups of tet genes, but not that it represents a substantial problem. Indeed, we are of the view that the change is imperative in the genomic era. From an epidemiological perspective, the context of the genes is also important and in some cases there is significant confusion already as a consequence of genes with different contexts being given the same name.
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Sir,
We respond to the comment by Warburton and Roberts 1 in reply to our recent call for rationalization of resistance gene nomenclature. 2 The authors argue that there will be more genes if the ,80% amino acid identity of the protein currently used in the case of genes conferring resistance to tetracycline is raised to ,2% DNA or protein as we proposed. We agree that this will be the case and that making the change may involve significant effort for a few groups of tet genes, but not that it represents a substantial problem. Indeed, we are of the view that the change is imperative in the genomic era. From an epidemiological perspective, the context of the genes is also important and in some cases there is significant confusion already as a consequence of genes with different contexts being given the same name.
A simple approach can be taken to change nomenclature for the tet genes. For example, the genes currently classified as tet(M) can be named tetM with a number for each distinct gene (tetM1, tetM2, etc.), thus retaining a connection with the system in current use. The number of sequences in the tet(M) group was stated by Warburton and Roberts, but the number of genes, assuming a 2% cut-off, was not. Given that many of these sequences are likely to differ by ,2% or perhaps correspond to hybrids, this should result in a modest number of numbered genes. A similar analysis can be repeated for each current group that includes multiple genes and, according to the current list at http://faculty.washington.edu/marilynr/ tetweb4.pdf, there are only a few groups that are affected. This includes four groups of genes encoding efflux proteins [tet(G), tet(K), tet(L) and tet(P)], three groups of genes encoding ribosomal protection proteins [tet(M), tet(O) and tet(W)] and enzymatic tet(X). Moreover, in most of these groups there is not a significant number of sequences and hence there will be only a few different genes.
We acknowledge the issue of mosaic resistance genes, which are found in a number of resistance gene families. This may best be handled using a system that indicates the order and origin of segments in the hybrid as suggested elsewhere.
3 Hence, we believe that workable solutions to this issue can be found and its existence should not preclude the urgently needed clarification of the diversity in the tet resistance genes currently given the same name.
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